| Breast cancer and climacteric complaints: weighing up risks of hormone therapy against quality of life. | |
| | |
MedLine Citation:
|
PMID: 17574325 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Women with severe menopausal symptoms can, at their request, be treated effectively with hormone therapy. Good information about the advantages and disadvantages of hormone therapy should precede this decision. For women with breast cancer or an inherited increased risk of breast cancer and severe, often therapy-related climacteric symptoms, a high degree of reticence is appropriate in relation to hormone therapy. If the quality of life is seriously affected in these often-young women with these iatrogenic climacteric complaints, then careful consideration must be given to the various treatment modalities. |
| | |
Authors:
|
Henk R Franke; Monique M A Brood-van Zanten; Curt W Burger; Marius J van der Mooren; Peter Kenemans |
Related Documents
:
|
16929115 - Immunohistochemical evaluation for hormone receptors in breast cancer: a practically us... 11369255 - Timing of breast cancer surgery in relation to the menstrual cycle: an update of develo... 7538695 - Hormone refractory disease. 3001995 - Hormonal agents and treatment of cancer. 20080315 - Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-bas... 16264935 - Mechanisms of disease: inflammatory mediators and cancer prevention. |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-06-18 |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 134 ISSN: 0301-2115 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 2007 Oct |
Date Detail:
|
Created Date: 2007-10-01 Completed Date: 2007-12-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: Ireland |
Other Details:
|
Languages: eng Pagination: 143-6 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Medisch Spectrum Twente Hospital Group, Enschede, The Netherlands. hfranke@xs4all.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Breast Neoplasms
/
complications,
epidemiology* Estrogen Receptor Modulators Estrogen Replacement Therapy Female Humans Menopause / drug effects* Netherlands Practice Guidelines as Topic Quality of Life Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Estrogen Receptor Modulators |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spontaneous gasping produces carotid blood flow during untreated cardiac arrest.
Next Document: Out of the wilderness? Achieving sustainable development within Scottish national parks.